ISO 27001 Certificate
SOC 1 Type I Certificate
SOC 2 Type II Certificate
PCI DSS
HIPAA
RGPD
Internal validation & live display
Multiple badges & continuous verification
Faster underwriting decisions
ISOSOC2 Type 1SOC2 Type 2PCI DSSHIPAAGDPR

Since 1987, Eurofins has grown from one laboratory in Nantes, France to over 65,000 staff across a network of independent companies in 60 countries, operating over 950 laboratories. Performing over 450 million tests every year, Eurofins offers a portfolio of over 200,000 analytical methods to evaluate the safety, identity, composition, authenticity, origin, traceability and purity of biological substances and products, as well as providing innovative clinical diagnostic testing services, as one of the leading global emerging players in specialised clinical diagnostics testing. Ever since its IPO on the French stock exchange in 1997, Eurofins has been one of the fastest growing listed European companies.

Eurofins A.I CyberSecurity Scoring

Eurofins

Company Details

Linkedin ID:

eurofins

Employees number:

25,341

Number of followers:

616,436

NAICS:

541714

Industry Type:

Biotechnology Research

Homepage:

eurofins.com

IP Addresses:

90

Company ID:

EUR_1422152

Scan Status:

Completed

AI scoreEurofins Risk Score (AI oriented)

Between 750 and 799

https://images.rankiteo.com/companyimages/eurofins.jpeg
Eurofins Biotechnology Research
Updated:
  • Powered by our proprietary A.I cyber incident model
  • Insurance preferes TPRM score to calculate premium
globalscoreEurofins Global Score (TPRM)

XXXX

https://images.rankiteo.com/companyimages/eurofins.jpeg
Eurofins Biotechnology Research
  • Instant access to detailed risk factors
  • Benchmark vs. industry & size peers
  • Vulnerabilities
  • Findings

Eurofins Company CyberSecurity News & History

Past Incidents
0
Attack Types
0
No data available
Ailogo

Eurofins Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

🔒
Incident Predictions locked
Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

🔒
A.I. Risk Score Predictions locked
Access Monitoring Plan
statics

Underwriter Stats for Eurofins

Incidents vs Biotechnology Research Industry Average (This Year)

No incidents recorded for Eurofins in 2025.

Incidents vs All-Companies Average (This Year)

No incidents recorded for Eurofins in 2025.

Incident Types Eurofins vs Biotechnology Research Industry Avg (This Year)

No incidents recorded for Eurofins in 2025.

Incident History — Eurofins (X = Date, Y = Severity)

Eurofins cyber incidents detection timeline including parent company and subsidiaries

Eurofins Company Subsidiaries

SubsidiaryImage

Since 1987, Eurofins has grown from one laboratory in Nantes, France to over 65,000 staff across a network of independent companies in 60 countries, operating over 950 laboratories. Performing over 450 million tests every year, Eurofins offers a portfolio of over 200,000 analytical methods to evaluate the safety, identity, composition, authenticity, origin, traceability and purity of biological substances and products, as well as providing innovative clinical diagnostic testing services, as one of the leading global emerging players in specialised clinical diagnostics testing. Ever since its IPO on the French stock exchange in 1997, Eurofins has been one of the fastest growing listed European companies.

Loading...
similarCompanies

Eurofins Similar Companies

bioMérieux

A family-owned company, bioMérieux has grown to become a world leader in the field of in vitro diagnostics. Our entrepreneurial adventure, begun over a century ago, is driven by an unrelenting commitment to improve public health worldwide. Since 1963, we've been paving the way in the field of in v

Amgen

Amgen harnesses the best of biology and technology to fight the world’s toughest diseases, and make people’s lives easier, fuller and longer. We helped establish the biotechnology industry, and we remain on the cutting-edge of innovation, using technology and human genetic data to push beyond what’s

Syneos Health

Syneos Health® is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success. We translate unique clinical, medical affairs and commercial insights into outcomes to address modern market realities. We bring together a talented team of professionals w

Avantor® is a leading global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. Our portfolio is used in virtually every stage of the most important research, development an

Biocon: Enhancing Global Healthcare Biocon Limited, publicly listed in 2004, is India's largest and fully-integrated, innovation-led biopharmaceutical company. It is an emerging global biopharmaceutical enterprise serving customers in over 120 countries. Driven by a vision to enhance global heal

CSL is a leading global biopharma company with a dynamic portfolio of lifesaving medicines, including those that treat haemophilia and immune deficiencies, vaccines to prevent influenza, and therapies in iron deficiency, dialysis and nephrology. Since our start in 1916, we have been driven by our pr

Charles River Laboratories

At Charles River, we are guided by our strong purpose—to create healthier lives—which centers around the patients who rely on the therapeutics we help to develop, the animals in our care, to our planet, and to the passionate and skilled people who are at the heart of our organization and make it all

ICON plc

Since our foundation in Dublin, Ireland in 1990, our mission has been to help our clients to accelerate the development of drugs and devices that save lives and improve quality of life. We do this by delivering best in class information, solutions and performance, with an unyielding focus on quality

Gilead Sciences

At Gilead, we set – and achieve – bold ambitions to create a healthier world for all people. From our pioneering virology medicines to our growing impact in oncology, we're delivering innovations once thought impossible in medicine. Our focus goes beyond medicines, and we also strive to remedy healt

newsone

Eurofins CyberSecurity News

August 13, 2025 07:00 AM
Dutch lab paid millions in ransom, but some data appeared online

Clinical Diagnostics paid millions in ransom after 485000 patient files were hacked. Nova criminals published only part of 300GB of data.

August 13, 2025 07:00 AM
Hackers breach cancer screening data of almost 500,000 women

Personal health data from more than 485000 women has been stolen from a cervical cancer screening programme in the Netherlands.

August 11, 2025 07:00 AM
Data breach at Dutch medical laboratory much larger than expected

Hackers steal data from 485000 women at a laboratory that conducts cervical cancer screening. Test results remain reliable.

March 05, 2025 05:50 PM
EY advises Medfiles on selling its Laboratory Division to Eurofins. | EY - Finland

Medfiles Ltd, a renowned contract research organization in Finland, announced the successful completion of the sale of its R&D and Analytical service...

March 26, 2024 07:00 AM
Eurofins E&E and ETS-Lindgren Complete Half-Million-Dollar Expansion to Silicon Valley EMC Testing Facility

Eurofins MET Labs is proud to announce the completion of a half-million-dollar expansion of its 10-meter EMC Chamber at their Santa Clara...

November 28, 2022 08:00 AM
Red teaming

Pictured is Dhruv Bisani, Eurofins Cyber Security's (Commissum) Head of Red Team, who writes of red teaming as a defence tactic against...

October 04, 2022 07:00 AM
Eurofins divests Digital Testing business

Eurofins Scientific has agreed to offload its Digital Testing business to Stirling Square Capital Partners in a 220 million deal.

September 30, 2022 07:00 AM
Eurofins divests its Digital Testing business

We have advised Eurofins Scientific (EUFI.PA), the global leader in food testing and a global scientific leader in bioanalytical testing,...

September 27, 2022 07:00 AM
White & Case advises Barings on unitranche financing for Stirling Square's acquisition of Eurofins Digital Testing

Global law firm White & Case LLP has advised investment management firm Barings on a unitranche financing for Stirling Square's acquisition...

faq

Frequently Asked Questions

Explore insights on cybersecurity incidents, risk posture, and Rankiteo's assessments.

Eurofins CyberSecurity History Information

Official Website of Eurofins

The official website of Eurofins is https://www.eurofins.com.

Eurofins’s AI-Generated Cybersecurity Score

According to Rankiteo, Eurofins’s AI-generated cybersecurity score is 783, reflecting their Fair security posture.

How many security badges does Eurofins’ have ?

According to Rankiteo, Eurofins currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Does Eurofins have SOC 2 Type 1 certification ?

According to Rankiteo, Eurofins is not certified under SOC 2 Type 1.

Does Eurofins have SOC 2 Type 2 certification ?

According to Rankiteo, Eurofins does not hold a SOC 2 Type 2 certification.

Does Eurofins comply with GDPR ?

According to Rankiteo, Eurofins is not listed as GDPR compliant.

Does Eurofins have PCI DSS certification ?

According to Rankiteo, Eurofins does not currently maintain PCI DSS compliance.

Does Eurofins comply with HIPAA ?

According to Rankiteo, Eurofins is not compliant with HIPAA regulations.

Does Eurofins have ISO 27001 certification ?

According to Rankiteo,Eurofins is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Industry Classification of Eurofins

Eurofins operates primarily in the Biotechnology Research industry.

Number of Employees at Eurofins

Eurofins employs approximately 25,341 people worldwide.

Subsidiaries Owned by Eurofins

Eurofins presently has no subsidiaries across any sectors.

Eurofins’s LinkedIn Followers

Eurofins’s official LinkedIn profile has approximately 616,436 followers.

NAICS Classification of Eurofins

Eurofins is classified under the NAICS code 541714, which corresponds to Research and Development in Biotechnology (except Nanobiotechnology).

Eurofins’s Presence on Crunchbase

Yes, Eurofins has an official profile on Crunchbase, which can be accessed here: https://www.crunchbase.com/organization/eurofins.

Eurofins’s Presence on LinkedIn

Yes, Eurofins maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/eurofins.

Cybersecurity Incidents Involving Eurofins

As of December 11, 2025, Rankiteo reports that Eurofins has not experienced any cybersecurity incidents.

Number of Peer and Competitor Companies

Eurofins has an estimated 4,470 peer or competitor companies worldwide.

Eurofins CyberSecurity History Information

How many cyber incidents has Eurofins faced ?

Total Incidents: According to Rankiteo, Eurofins has faced 0 incidents in the past.

What types of cybersecurity incidents have occurred at Eurofins ?

Incident Types: The types of cybersecurity incidents that have occurred include .

Incident Details

What are the most common types of attacks the company has faced ?

Additional Questions

cve

Latest Global CVEs (Not Company-Specific)

Description

FreePBX Endpoint Manager is a module for managing telephony endpoints in FreePBX systems. Versions prior to 16.0.96 and 17.0.1 through 17.0.9 have a weak default password. By default, this is a 6 digit numeric value which can be brute forced. (This is the app_password parameter). Depending on local configuration, this password could be the extension, voicemail, user manager, DPMA or EPM phone admin password. This issue is fixed in versions 16.0.96 and 17.0.10.

Risk Information
cvss4
Base: 6.9
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:L/VI:L/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description

Neuron is a PHP framework for creating and orchestrating AI Agents. In versions 2.8.11 and below, the MySQLWriteTool executes arbitrary SQL provided by the caller using PDO::prepare() + execute() without semantic restrictions. This is consistent with the name (“write tool”), but in an LLM/agent context it becomes a high-risk capability: prompt injection or indirect prompt manipulation can cause execution of destructive queries such as DROP TABLE, TRUNCATE, DELETE, ALTER, or privilege-related statements (subject to DB permissions). Deployments that expose an agent with MySQLWriteTool enabled to untrusted input and/or run the tool with a DB user that has broad privileges are impacted. This issue is fixed in version 2.8.12.

Risk Information
cvss3
Base: 9.4
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:H/A:H
Description

Neuron is a PHP framework for creating and orchestrating AI Agents. Versions 2.8.11 and below use MySQLSelectTool, which is vulnerable to Read-Only Bypass. MySQLSelectTool is intended to be a read-only SQL tool (e.g., for LLM agent querying, however, validation based on the first keyword (e.g., SELECT) and a forbidden-keyword list does not block file-writing constructs such as INTO OUTFILE / INTO DUMPFILE. As a result, an attacker who can influence the tool input (e.g., via prompt injection through a public agent endpoint) may write arbitrary files to the DB server if the MySQL/MariaDB account has the FILE privilege and server configuration permits writes to a useful location (e.g., a web-accessible directory). This issue is fixed in version 2.8.12.

Risk Information
cvss3
Base: 8.2
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:H/A:N
Description

Okta Java Management SDK facilitates interactions with the Okta management API. In versions 11.0.0 through 20.0.0, race conditions may arise from concurrent requests using the ApiClient class. This could cause a status code or response header from one request’s response to influence another request’s response. This issue is fixed in version 20.0.1.

Risk Information
cvss3
Base: 8.4
Severity: HIGH
CVSS:3.1/AV:N/AC:H/PR:L/UI:N/S:C/C:H/I:H/A:L
Description

The Auth0 Next.js SDK is a library for implementing user authentication in Next.js applications. When using versions 4.11.0 through 4.11.2 and 4.12.0, simultaneous requests on the same client may result in improper lookups in the TokenRequestCache for the request results. This issue is fixed in versions 4.11.2 and 4.12.1.

Risk Information
cvss3
Base: 5.4
Severity: HIGH
CVSS:3.1/AV:N/AC:H/PR:L/UI:R/S:U/C:H/I:L/A:N

Access Data Using Our API

SubsidiaryImage

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?linkedin_id=eurofins' -H 'apikey: YOUR_API_KEY_HERE'

What Do We Measure ?

revertimgrevertimgrevertimgrevertimg
Incident
revertimgrevertimgrevertimgrevertimg
Finding
revertimgrevertimgrevertimgrevertimg
Grade
revertimgrevertimgrevertimgrevertimg
Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network Security

Identify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)

Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)

Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat Intelligence

Leverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Top LeftTop RightBottom LeftBottom Right
Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.
Users Love Us Badge